Expression of MicroRNAs in Thyroid Carcinoma

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• MicroRNAs (miRNAs) are crucial negative regulators of gene expression, controlling cellular processes like development, signaling, metabolism, and apoptosis.
• Aberrant miRNA expression is frequently observed in various cancers, including thyroid malignancies, suggesting a role in oncogenesis.
• Thyroid cancers encompass several subtypes, including papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), anaplastic thyroid cancer (ATC), and medullary thyroid carcinoma (MTC).

Purpose of the Study:

• To review current research on microRNA dysregulation in thyroid cancers.
• To identify specific dysregulated miRNAs and their associated regulatory pathways in different thyroid cancer types.
• To discuss the oncogenic and pathological significance of these dysregulated miRNAs.

Main Methods:

• Systematic literature review of studies investigating miRNA expression in thyroid cancer.
• Identification and analysis of dysregulated miRNAs across PTC, FTC, ATC, and MTC.
• Examination of associated molecular pathways and their role in thyroid tumorigenesis.

Main Results:

• Numerous miRNAs exhibit altered expression patterns in thyroid cancers compared to normal thyroid tissue.
• Specific miRNAs are linked to key cellular processes implicated in thyroid cancer progression, such as proliferation, invasion, and metastasis.
• Dysregulation of miRNA pathways contributes to the distinct pathological features of different thyroid cancer subtypes.

Conclusions:

• MicroRNA dysregulation plays a significant role in the initiation and progression of thyroid cancers.
• Understanding these miRNA alterations offers potential for novel diagnostic and therapeutic strategies in thyroid oncology.
• Further research into specific miRNA-pathway interactions is warranted to fully elucidate their oncogenic functions.